In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report). The ...

Eton Pharma announces positive results from bioequivalence study of ET-600 to treat central diabetes insipidus: Deer Park, Illinois Monday, March 17, 2025, 18:00 Hrs [IST] Eton Ph ...

Eton Pharmaceuticals (ETON) announced positive results from its bioequivalence study of ET-600, a proprietary, patented oral solution of ...

Eton Pharmaceuticals' ET-600 met bioequivalence standards in a study, with an FDA filing planned for April 2025 and a ...

March 14, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing ...

Galzin (zinc acetate capsules) is now available for maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent.

Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership ...

Eton Pharmaceuticals (NASDAQ:ETON – Get Free Report) will likely be issuing its quarterly earnings data before the market opens on Thursday, March 13th. Analysts expect the company to announce ...

(RTTNews) - Eton Pharmaceuticals (ETON) announced positive results from bioequivalence study of ET-600, a patented oral solution of desmopressin under development for the treatment of central ...

Here is how 89BIO (ETNB) and Eton Pharmaceuticals, Inc. (ETON) have performed compared to their sector so far this year. DEER PARK, Ill., March 04, 2025 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals ...

For nearly a quarter of a century, Tom Dunbar has ruled the game of Eton Fives. The sport, a form of handball which is largely the preserve of Britain’s top private schools, is played on a court ...